$BFLY

ROBBINS LARRY sold $20.6M of BFLY (indirect holdings)

ROBBINS LARRY sold 2,297,733 indirectly-held shares of Butterfly Network, Inc. (BFLY) at an average of $8.98 ($8.70–$9.54, $20.62M total) across 5 trades over 2026-08-13 to 2026-08-17.

Original reporting
SEC EDGAR · ROBBINS LARRY
Published Aug 17, 2026, 11:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 17, 2026, 11:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$BFLY
Neutral
medium confidence
Mentioned
$BFLY
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BFLYNeutralLow
01

Why it matters

Traders may reassess near-term sentiment around BFLY due to the transaction size ($20.62M) and the absence of a stated 10b5-1 plan, but there is no accompanying fundamental update in the text.

02

Market read

The only new information is the insider sale details (shares, price range, total value, and post-transaction holdings).

03

What to watch

The filing does not specify the reason for the sale, and it states no pre-arranged 10b5-1 plan, which can increase headline sensitivity without proving information content.

Relevance 7/10Novelty 4/10Timing: filed 2026-08-17, covering sales from 2026-08-13 to 2026-08-17

Background

This is an SEC Form 4 insider transaction for Butterfly Network, Inc. (BFLY) by director Larry Robbins, reported as an indirect holding sale.

Company-level read

Ticker impact

$BFLYNeutralMedium confidence
Context

Butterfly Network director Larry Robbins sold $20.62M of BFLY shares via an open-market sale across five trades at $8.6973 to $9.5418.

Expected impact

Near-term sentiment could soften, but follow-through is likely limited absent additional company-specific catalysts.

Evidence & confidence

Form 4 confirms transaction size and pricing range, yet the article provides no new operational, financial, or regulatory development for BFLY.

Market effects

No direct sector read-through beyond routine insider activity in medical imaging/diagnostics.

None indicated.

None indicated.

Counterpoint

A large indirect sale can reflect diversification or liquidity needs rather than negative expectations, especially when multiple trades are spread across days.

Key entities

  • Butterfly Network, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Larry Robbins

    Director who sold 2,297,733 shares indirectly in open-market transactions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BFLYMed

Butterfly Network (BFLY) Is Up 24.2% After Raising 2026 Guidance And Narrowing Losses - Has The Bull Case Changed?

Butterfly Network (BFLY) shares rose 24.2% after the company reported Q2 2026 revenue of $32.61M and a reduced net loss of $12.91M, and raised 2026 revenue guidance to $119M to $123M. The article cites improving losses and momentum in Embedded partnerships and enterprise point-of-care ultrasound, while noting ongoing cash burn and potential dilution risks.

$BFLYMedAI 9/10

Butterfly (BFLY) Q2 2026 Earnings Call Transcript

Butterfly Network (BFLY) reported Q2 2026 revenue of $32.6M, up 39% y/y, driven by Embedded revenue of $10.8M (+439%). Gross profit rose to $23.3M and gross margin to 71%. Adjusted EBITDA loss narrowed to $1.4M. Q3 revenue guidance is $26M to $30M, and FY2026 revenue guidance is $119M to $123M.

$BFLYMedAI 8/10

Butterfly Network, Inc. Q2 2026 Earnings Call Summary

Butterfly Network, Inc. reported Q2 2026 progress driven by POCUS, Home and Community Care, and Embedded partnerships. Embedded revenue rose 439% on the Midjourney partnership. Gross margin was 71%. Full-year 2026 revenue guidance was raised to $119 million-$123 million. Home and Community Care first commercial implementation starts Oct 1, with revenue in Q4 2026.

$BFLYMedAI 8/10

Butterfly (BFLY) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Chief Financial Officer - John Doherty Chairman and Chief Executive Officer - Joseph DeVivo TAKEAWAYS Revenue -- $32.6 million, an increase of 39% year over year driven primarily by the growth of the Butterfly Embedded segment. Embedded Revenue -- $10.8 million, representing 439% year-over-year growth due to development work and milestones from the Midjourney partnership.